June 15, 2009FDA: First Drug to Treat Cancer in Dogs Approved FDA: First Drug to Treat Cancer in Dogs Approved
The U.S. Food and Drug Administration today announced the approval of Palladia (toceranib phosphate), the first drug developed specifically for the treatment of cancer in dogs. Source: www.fda.gov FDA Alerts Consumers to Recall of Water-Based Face Paints The Food and Drug Administration is advising consumers to stop using certain cosmetic “Face Paint” items labeled as distributed by Oriental Trading Co., Omaha, Neb., due to adverse event reports of skin reactions in children. These items were distributed nationwide. Source: www.fda.gov FDA Warns Consumers Not to Use Skin Products Made by Clarcon Due to Bacterial Contamination Risk The U.S. Food and Drug Administration announced today that Clarcon Biological Chemistry Laboratory Inc. of Roy, Utah, is voluntarily recalling some skin sanitizers and skin protectants marketed under several different brand names because of high levels of disease-causing bacteria found in the product during a recent inspection. The FDA is warning consumers to not use any Clarcon products. Source: www.fda.gov U.S. Attorney News Release: California Man Sentenced for Prescription Drug Diversion CONCORD, NEW HAMPSHIRE: Thomas Lavery, of Irvine, CA, was sentenced to 52 months of incarceration to be followed by three years of supervised release for illegally distributing large quantities of Serostim, an HIV drug, which were illegally purchased from illegitimate sources and then illegally sold to wholesale distributors in various parts of the country, using falsified paperwork. Judge McAuliffe also entered an order of forfeiture against Lavery for the sum of $1,009,460. Source: www.fda.gov FDA Warns Consumers to Stop Using Hydroxycut Products The U.S. Food and Drug Administration is warning consumers to immediately stop using Hydroxycut products by Iovate Health Sciences Inc., of Oakville, Ontario and distributed by Iovate Health Sciences USA Inc. of Blasdell, N.Y. Some Hydroxycut products are associated with a number of serious liver injuries. Iovate has agreed to recall Hydroxycut products from the market. Source: www.fda.gov # posted by Network @ 2:06 PM
 |
Subscribe to Posts [Atom]